- UroToday Home
- Urologic Oncology
The Latest Renal Cancer Research
Recent Abstracts
-
Safety and efficacy of CDX-014, an antibody-drug conjugate directed against T cell immunoglobulin mucin-1 in advanced renal cell carcinoma.Renal CancerJune 2, 2020
-
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma.Renal CancerJune 2, 2020
-
Sunitinib Versus Sorafenib as Initial Targeted Therapy for mCC-RCC With Favorable/Intermediate Risk: Multicenter Randomized Trial CROSS-J-RCC.Renal CancerJune 1, 2020
-
Efficacy of Savolitinib vs Sunitinib in Patients With MET-Driven Papillary Renal Cell Carcinoma The SAVOIR Phase 3 Randomized Clinical TrialRenal CancerMay 29, 2020
-
Comprehensive analysis of the HOXA gene family identifies HOXA13 as a novel oncogenic gene in kidney renal clear cell carcinoma.Renal CancerMay 29, 2020
-
New Treatments in Renal Cancer: The AhR Ligands.Renal CancerMay 29, 2020
-
Identification of low-dose multidrug combinations for sunitinib-naive and pre-treated renal cell carcinoma.Renal CancerMay 28, 2020
-
Personalized neoantigen-based immunotherapy for advanced collecting duct carcinoma: case report.Renal CancerMay 28, 2020
-
Assessing Genomic Copy Number Alterations as Best Practice for Renal Cell Neoplasia: An Evidence-Based Review from the Cancer Genomics Consortium Workgroup.Renal CancerMay 28, 2020
-
Partial vs. radical nephrectomy and the risk of all-cause mortality, cardiovascular, and nephrological outcomes.Renal CancerMay 28, 2020
Beyond the Abstracts
-
Segmental Ureterectomy vs. Radical Nephroureterectomy for Ureteral Carcinoma in Patients with a Preoperative Glomerular Filtration Rate Less Than 90 ml/min/1.73 m2: A Multicenter Study - Beyond the AbstractRenal CancerMay 12, 2020
-
First-Line Treatment of Metastatic Renal Cell Carcinoma in the Immuno-Oncology Era: Systematic Review and Network Meta-analysis - Beyond the AbstractRenal CancerMay 11, 2020
-
Comparison of Survival Outcomes in Patients with Metastatic Papillary vs. Clear-Cell Renal Cell Carcinoma: A Propensity-Score Analysis - Beyond the AbstractRenal CancerMay 6, 2020
-
Psychological Distress Associated with Active Surveillance in Patients Younger than 70 with A Small Renal Mass - Beyond the AbstractRenal CancerApril 29, 2020
-
Survival Outcomes and Practice Trends for Off-Label Use of Adjuvant Targeted Therapy in High-Risk Locoregional Renal Cell Carcinoma - Beyond the AbstractRenal CancerApril 24, 2020
-
Bridging the Gap with Evolving Kidney Cancer Preclinical Models - Beyond the AbstractRenal CancerApril 8, 2020
-
Cell Cycle Progression Score Has Potential Prognostic Value for Stage T1 Renal Cell Carcinomas - Beyond the AbstractRenal CancerMarch 23, 2020
-
The Covalent CDK7 Inhibitor THZ1 Enhances Temsirolimus-Induced Cytotoxicity via Autophagy Suppression in Human Renal Cell Carcinoma - Beyond the AbstractRenal CancerFebruary 4, 2020
-
Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses - Beyond the AbstractRenal CancerJanuary 16, 2020
-
Facts for Spontaneous Rupture of a Renal Cell Carcinoma with Fatal Bleeding - Beyond the AbstractRenal CancerJanuary 9, 2020